Nanobodies targeting ABCC3 for immunotargeted applications in glioblastoma.

Autor: Ruiz-López E; Molecular Oncology Group, Instituto de Investigación Sanitaria Aragón (IIS Aragón), 50009, Zaragoza, Spain., Jovčevska I; Center for Functional Genomics and Biochips, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., González-Gómez R; Molecular Oncology Group, Instituto de Investigación Sanitaria Aragón (IIS Aragón), 50009, Zaragoza, Spain., Tejero H; Bioinformatics Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029, Madrid, Spain., Al-Shahrour F; Bioinformatics Unit, Centro Nacional de Investigaciones Oncológicas (CNIO), 28029, Madrid, Spain., Muyldermans S; Cellular and Molecular Immunology, Vrije Universiteit Brussel, Pleinlaan 2, 1050, Brussels, Belgium., Schuhmacher AJ; Molecular Oncology Group, Instituto de Investigación Sanitaria Aragón (IIS Aragón), 50009, Zaragoza, Spain. ajimenez@iisaragon.es.; Fundación Aragonesa para la Investigación y el Desarrollo (ARAID), 50018, Zaragoza, Spain. ajimenez@iisaragon.es.

Publikováno v: Scientific reports [Sci Rep] 2022 Dec 30; Vol. 12 (1), pp. 22581. Date of Electronic Publication: 2022 Dec 30.

Fatty acids homeostasis during fasting predicts protection from chemotherapy toxicity.

Autor: Barradas M; Metabolic Syndrome Group-BIOPROMET, CEI UAM+CSIC, Madrid Institute for Advanced Studies-IMDEA Food, Madrid, Spain. marta.barradas@imdea.org., Plaza A; Metabolic Syndrome Group-BIOPROMET, CEI UAM+CSIC, Madrid Institute for Advanced Studies-IMDEA Food, Madrid, Spain. adrian.plaza@imdea.org., Colmenarejo G; Biostatistics and Bioinformatics Unit, CEI UAM+CSIC, Madrid Institute for Advanced Studies-IMDEA Food, Madrid, Spain., Lázaro I; Cardiovascular risk and nutrition, Hospital del Mar Medical Research Institute-IMIM, Barcelona, Spain., Costa-Machado LF; Metabolic Syndrome Group-BIOPROMET, CEI UAM+CSIC, Madrid Institute for Advanced Studies-IMDEA Food, Madrid, Spain., Martín-Hernández R; Biostatistics and Bioinformatics Unit, CEI UAM+CSIC, Madrid Institute for Advanced Studies-IMDEA Food, Madrid, Spain., Micó V; Nutritional Genomics of Cardiovascular Disease and Obesity, Madrid Institute for Advanced Studies-IMDEA Food, Madrid, Spain., López-Aceituno JL; Metabolic Syndrome Group-BIOPROMET, CEI UAM+CSIC, Madrid Institute for Advanced Studies-IMDEA Food, Madrid, Spain., Herranz J; Biostatistics and Bioinformatics Unit, CEI UAM+CSIC, Madrid Institute for Advanced Studies-IMDEA Food, Madrid, Spain., Pantoja C; Metabolic Syndrome Group-BIOPROMET, CEI UAM+CSIC, Madrid Institute for Advanced Studies-IMDEA Food, Madrid, Spain., Tejero H; Bioinformatics Unit, Spanish National Cancer Research Centre-CNIO, Madrid, Spain., Diaz-Ruiz A; Nutritional Interventions Group, Precision Nutrition and Aging, CEI UAM+CSIC, Madrid Institute for Advanced Studies-IMDEA Food, Madrid, Spain., Al-Shahrour F; Bioinformatics Unit, Spanish National Cancer Research Centre-CNIO, Madrid, Spain., Daimiel L; Nutritional Genomics of Cardiovascular Disease and Obesity, Madrid Institute for Advanced Studies-IMDEA Food, Madrid, Spain., Loria-Kohen V; Nutrition and Clinical Trials Unit, Platform GENYAL, CEI UAM+CSIC, Madrid Institute for Advanced Studies-IMDEA Food, Madrid, Spain., Ramirez de Molina A; Nutrition and Clinical Trials Unit, Platform GENYAL, CEI UAM+CSIC, Madrid Institute for Advanced Studies-IMDEA Food, Madrid, Spain.; Molecular Oncology and Nutritional Genomics of Cancer Group, CEI UAM+CSIC, Madrid Institute for Advanced Studies-IMDEA Food, Madrid, Spain., Efeyan A; Metabolism and Cell Signaling Group, Spanish National Cancer Research Centre-CNIO, Madrid, Spain., Serrano M; Institute for Research in Biomedicine (IRB Barcelona), Barcelona Institute of Science and Technology (BIST), Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain., Pozo OJ; Applied Metabolomics Research Group, Hospital del Mar Medical Research Institute-(IMIM), Barcelona, Spain., Sala-Vila A; Cardiovascular risk and nutrition, Hospital del Mar Medical Research Institute-IMIM, Barcelona, Spain.; Fatty Acid Research Institute, Sioux Falls, SD, USA., Fernandez-Marcos PJ; Metabolic Syndrome Group-BIOPROMET, CEI UAM+CSIC, Madrid Institute for Advanced Studies-IMDEA Food, Madrid, Spain. pablojose.fernandez@imdea.org.

Publikováno v: Nature communications [Nat Commun] 2022 Sep 27; Vol. 13 (1), pp. 5677. Date of Electronic Publication: 2022 Sep 27.

A molecular hypothesis to explain direct and inverse co-morbidities between Alzheimer's Disease, Glioblastoma and Lung cancer

Autor: Sánchez-Valle J, Tejero H, Ibáñez K, Portero JL, Krallinger M, Al-Shahrour F, Tabarés-Seisdedos R, Baudot A, Valencia A

Publikováno v: Scientific Reports
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::58410c097ff9c5286b5a109634ccdbc8
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2082

Plasticity and Tumor Microenvironment in Pancreatic Cancer: Genetic, Metabolic, and Immune Perspectives.

Autor: Hashimoto, Ari¹ (AUTHOR) ahashimo@med.hokudai.ac.jp, Hashimoto, Shigeru² (AUTHOR) ahashimo@med.hokudai.ac.jp

Publikováno v: Cancers. Dec2024, Vol. 16 Issue 23, p4094. 41p.

Effects of Biguanide-PROTACs in Pancreatic Cancer Cells.

Autor: Vatté, Julie¹ (AUTHOR), Bourdeau, Véronique² (AUTHOR) g.ferbeyre@umontreal.ca, Ferbeyre, Gerardo^2,3 (AUTHOR), Schmitzer, Andreea R.¹ (AUTHOR) ar.schmitzer@umontreal.ca

Publikováno v: Molecules. Nov2024, Vol. 29 Issue 22, p5329. 26p.